Martin S. Maron on Muck Rack

Martin S. Maron

Boston
As seen in: Wiley Online Library, heart, Taylor & Francis Online, AHA/ASA Journals, Healio, Healio Cardiology, HCP Live, HMP Global Learning Network, JACC (Journal of the American College of Cardiology), JACC: Cardiovascular Imaging and
Is this you? As a journalist, you can create a free Muck Rack account to customize your profile, list your contact preferences, and upload a portfolio of your best work. Claim your profile

Get in touch with Martin S.

Contact Martin S., search articles and posts on X, monitor coverage, and track replies from one place.

Learn more about Muck Rack

Actions

Share this page

Is this you?

As a journalist, you can create a free Muck Rack account to customize your profile, list your contact preferences, and upload a portfolio of your best work.
Claim your profile

Articles

Mavacamten in Obstructive Hypertrophic Cardiomyopathy: National Insights on Access and Safety Profile From Real‐World Data

|
By Martin S. Maron, Ethan J. Rowin
| AHA/ASA Journals
Research Article Open Access Nonstandard Abbreviations and Acronyms HCM hypertrophic cardiomyopathy REMS Risk Evaluation and Mitigation Strategy SRT septal reduction therapy Clinical Perspectives • In a large real‐world cohort of patients with obstructive hypertrophic cardiomyopathy, mavacamten was prescribed more often in women and less likely in Black patients and was associated with an 8.3% incidence of left ventricular systolic dysfunction and a 4.8% incidence of acute heart failure,...
Open in Who Shared Issue with article?

Invasive Treatment Options in Hypertrophic Cardiomyopathy

|
By Martin S. Maron, Florian Rader, Mariko Harper, Viet Le Verified
| consultantlive.com
Understanding Hypertrophic Cardiomyopathy: From Disease Mechanisms to Clinical Management - Episode 8 Published on: , , , Learn when cardiac myosin inhibitors suffice and when myectomy or alcohol ablation fits, with shared decisions at expert HCM centers. In the final episode, Invasive Treatment Options in Hypertrophic Cardiomyopathy, the panelists explored the following critical question: What is the role of invasive procedures for hypertrophic cardiomyopathy?
Open in Who Shared View Duplicates (2) Issue with article?

Insights from the MAPLE Trial: Clinical Implications for oHCM Management

|
By Martin S. Maron, Florian Rader, Mariko Harper, Viet Le Verified
| consultantlive.com
Understanding Hypertrophic Cardiomyopathy: From Disease Mechanisms to Clinical Management - Episode 7 Published on: , , , MAPLE HCM reveals aficamten beats beta blockers in obstructive HCM, reshaping first-line therapy debates amid insurance hurdles. This episode, titled Insights from the MAPLE Trial: Clinical Implications for oHCM Management, features panelists discussing the following question: Can you please discuss the MAPLE trial and its clinical implications? Led by Dr. Maron, Drs.
Open in Who Shared View Duplicates (2) Issue with article?
See all 39 licensed articles (67 Total)
 •  Privacy  •  Terms  •  Security and Legal  •   •   •   • 

© 2026 Muck Rack

SOC 2® Certified